Arrow Electronics, Inc. (NYSE:ARW) announced that William F. Austen, retired president, chief executive officer, and director of Bemis Company, Inc., has been elected to the company's board of directors. The election of Mr. Austen leaves the total number of directors on the board at ten
Change Healthcare Inc. (Nasdaq: CHNG), a leading independent healthcare technology company, announced today that Nella Domenici, currently a member of the Board of Alliance Bernstein LP, and former chief financial officer of Bridgewater Associates, has been appointed to the Change Healthcare Board of Directors...
Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Seth H.Z. Fischer to its Board of Directors...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the appointment of Timothy P. Walbert, chairman, president and chief executive officer (CEO) of Horizon Therapeutics plc, to the Company’s Board of Directors...
Incyte (Nasdaq:INCY) announces the appointment of Katherine High, M.D., as a new member of the Board of Directors, effective March 25, 2020...